• Allergic Conjunctivitis
    • Add/adhd Kols
    • Key People For Allergic Conjunctivitis

      Top KOLs in the world
      Mark B Abelson
      allergic conjunctivitis dry eye ophthalmic solution
      Leonard Bielory
      allergic conjunctivitis ocular allergy united states
      Andrea A Leonardi
      vernal keratoconjunctivitis allergic conjunctivitis ocular allergy
      Giorgio Walter Canonica
      allergic rhinitis severe asthma sublingual immunotherapy
      Sergio Bonini
      allergic rhinitis nerve growth factor vernal keratoconjunctivitis
      Mathea R Allansmith
      vernal conjunctivitis mast cells ocular anaphylaxis

      γδ T Cells Are Required for Maximal Expression of Allergic Conjunctivitis


      PURPOSE: To determine the function of γδ T cells in early- and late-phase responses in allergic conjunctivitis.

      METHODS: Wild-type (WT) C57BL/6 and γδ T cell-deficient (TCR-δ(-/-)) mice were immunized intraperitoneally and challenged topically for 7 consecutive days with short ragweed pollen. Natural killer T (NKT) and γδ T cell-double-deficient mice were generated by treating TCR-δ(-/-) mice with anti-CD1d antibody. Allergic conjunctivitis was evaluated clinically, and the late-phase response was assessed by histopathology. Cytokine profiles were evaluated by ELISA. The afferent and efferent arms of allergic conjunctivitis were assessed by adoptive transfer of CD4(+) T cells from WT or TCR-δ(-/-) mice into naive TCR-δ(-/-) or WT mice.

      RESULTS: TCR-δ(-/-) mice had decreased clinical manifestations of allergic conjunctivitis compared with WT mice. TCR-δ(-/-) mice had decreased eosinophilic infiltration compared with WT mice. TCR-δ(-/-) mice produced less Th2-associated cytokines interleukin (IL)-4, -5, and -13 compared with WT mice. Clinical manifestations of allergic conjunctivitis were lowest in NKT cell-depleted TCR-δ(-/-) mice. However, late-phase allergic conjunctivitis in NKT cell-depleted, TCR-δ(-/-) mice was the same as TCR-δ(-/-) mice. Adoptive transfer of CD4(+) T cells revealed that γδ T cells are needed for the afferent and efferent arms of allergic conjunctivitis.

      CONCLUSIONS: γδ T cells are needed for full expression of both the clinical manifestations and the late phase of allergic conjunctivitis. Thus, γδ T cells have an important impact in the expression of allergic conjunctivitis and are a potential therapeutic target in the management of allergic diseases of the ocular surface.

      Sign-in to see all concepts, it's free!


    Download on the App StoreGet it on Google Play

    Copyright © 2023 - KOL means Key Opinion Leaders .

    KOL does not provide medical advice, diagnosis or treatment.